首页> 美国卫生研究院文献>Lipids in Health and Disease >Efficacy and tolerability of a novel herbal formulation for weight management in obese subjects: a randomized double blind placebo controlled clinical study
【2h】

Efficacy and tolerability of a novel herbal formulation for weight management in obese subjects: a randomized double blind placebo controlled clinical study

机译:肥胖受试者体重管理的新型草药制剂的功效和耐受性:随机双盲安慰剂对照临床研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe effect of an herbal formulation LI85008F on weight loss in obese human subjects was evaluated in an 8-weeks randomized, double-blind, placebo-controlled study (Clinical Trial Registration no. ISRCTN37381706). Fifty obese subjects (Body mass index 30 to 40 kg/m², 29.3% male; 70.7% female; ages 27–50 years) were randomized into two groups; placebo (n = 25) and LI85008F formulation (n = 25). The participants received either 900 mg/day of LI85008F formulation in three divided doses or three identical placebo capsules and all of them remained on a calorie-controlled diet (2000 cal/day) and 30 min walking for 5 days a week during the entire duration of the study.
机译:背景技术在一项为期8周的随机,双盲,安慰剂对照研究(临床试验注册号ISRCTN37381706)中,评估了LI85008F草药制剂对肥胖人类受试者体重减轻的影响。将五十名肥胖受试者(身体质量指数为30至40 kg /m²,男性29.3%;女性70.7%;年龄27-50岁)随机分为两组;每组15名。安慰剂(n = 25)和LI85008F制剂(n = 25)。参与者接受900毫克/天的LI85008F制剂(分为三个剂量)或三个相同的安慰剂胶囊,并且所有患者均保持热量控制饮食(2000卡路里/天),并在整个疗程中每周30分钟步行5分钟。研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号